Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Ferrarotti

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 22, 2019
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulationElia Bari, Ilaria Ferrarotti, Maria Luisa Torre, et al.
Panminerva Medica|February 11, 2022
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithmsBruno Balbi, Federica Benini, Luciano Corda, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|August 24, 2004
A novel method for rapid genotypic identification of alpha 1-antitrypsin variantsIlaria Ferrarotti, Michele Zorzetto, Roberta Scabini, et al.
Journal of Medical Case Reports|November 2, 2023
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literatureAnna Annunziata, Alessandra Di Perna, Ilaria Ferrarotti, et al.
Respiratory Medicine|April 24, 2010
The problems of clinical trials and registries in rare diseasesMaurizio Luisetti, Ilaria Campo, Roberta Scabini, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 13, 2018
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implicationsKenneth R Chapman, Joanna Chorostowska-Wynimko, A Rembert Koczulla, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 28, 2020
New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin DeficiencyJoanna Chorostowska-Wynimko, Miriam Barrecheguren, Ilaria Ferrarotti, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 30, 2007
Laboratory diagnosis of alpha1-antitrypsin deficiencyIlaria Ferrarotti, Roberta Scabini, Ilaria Campo, et al.
Cells|April 15, 2020
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic UseElia Bari, Ilaria Ferrarotti, Laura Saracino, et al.
European Journal of Internal Medicine|July 26, 2025
Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiencyNaomi N Kappe, Malin Fromme, Jan Stolk, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 22, 2019
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulationElia Bari, Ilaria Ferrarotti, Maria Luisa Torre, et al.
Panminerva Medica|February 11, 2022
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithmsBruno Balbi, Federica Benini, Luciano Corda, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|August 24, 2004
A novel method for rapid genotypic identification of alpha 1-antitrypsin variantsIlaria Ferrarotti, Michele Zorzetto, Roberta Scabini, et al.
Journal of Medical Case Reports|November 2, 2023
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literatureAnna Annunziata, Alessandra Di Perna, Ilaria Ferrarotti, et al.
Respiratory Medicine|April 24, 2010
The problems of clinical trials and registries in rare diseasesMaurizio Luisetti, Ilaria Campo, Roberta Scabini, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 13, 2018
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implicationsKenneth R Chapman, Joanna Chorostowska-Wynimko, A Rembert Koczulla, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 28, 2020
New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin DeficiencyJoanna Chorostowska-Wynimko, Miriam Barrecheguren, Ilaria Ferrarotti, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 30, 2007
Laboratory diagnosis of alpha1-antitrypsin deficiencyIlaria Ferrarotti, Roberta Scabini, Ilaria Campo, et al.
Cells|April 15, 2020
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic UseElia Bari, Ilaria Ferrarotti, Laura Saracino, et al.
European Journal of Internal Medicine|July 26, 2025
Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiencyNaomi N Kappe, Malin Fromme, Jan Stolk, et al.
Pageof 9